Update on Study 19 trial of olaparib in serous ovarian cancer

Jonathan Ledermann, MD, FRCP from University College London, London, UK discusses his presentation on the update on the results of the Study 19 trial (NCT00753545). Study 19 was a randomized maintenan... Author: VJOncology Added: 08/17/2016
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts